北京时间2024年11月4日,Bicycle Therapeutics Limited(纳斯达克代码:BCYC)股价盘中出现大涨行情,截至收盘上涨5.44%,报收23.88美元。
Bicycle Therapeutics是一家临床阶段的生物制药公司,专注于开发一种被称为Bicycles的新型药物。其主要候选产品BT1718是一种Bicycle毒素结合物,旨在成为肿瘤学领域的新型疗法。
公开数据显示,在14家机构对该公司进行评级中,有12家给予买入评级,占比高达86%,市场对公司产品前景持看好态度。这可能是推动该股周一盘中大涨的主要原因。不过公司具体有何重大利好消息目前并未披露。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.